Drugs / FLUCON®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04376970 Comparator | Apr 2017 → Apr 2019 | epidemic keratoconjunctivitis | Military Hospital of Tunis | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FLUCON | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04376970 ↗ |
| Route | Topical | “topical fluorometholone 0.1% (FLUCON®)” NCT04376970 ↗ |